BioSpace News Archive

Arcutis Biotherapeutics, Inc. announced a new patent issued by the United States Patent and Trademark Office covering its invention for improving delivery and extending half-life of both the cream and foam formulations of topical roflumilast.

Syros Pharmaceuticals, a leader in the development of medicines that control the expression of genes, announced the grant of an inducement stock option award to Conley Chee, the Company’s recently hired Chief Commercial Officer, in accordance with Mr. Chee’s employment offer letter.

Ocular Therapeutix, Inc. today announced the appointment of Karen-Leigh Edwards as Senior Vice President of Technical Operations.

Pear Therapeutics to Participate in the Sachs Associates 8th Annual HealthTech Investment Forum

Moderna to Present at Chardan’s Virtual 5th Annual Genetic Medicines Conference

Kineta, Inc. announced today that it will present a poster on the company’s new anti-CD27 agonist antibody program at the American Association for Cancer Research (AACR) Virtual Special Conference: Tumor Immunology and Immunotherapy

Humanigen plans to submit an MAA under the centralized procedure seeking Conditional Marketing Authorization (CMA) throughout the European Union (EU) for the use of lenzilumab to treat patients hospitalized with COVID-19 pneumonia

Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) today announced the publication of an article entitled, “Coronary sinus narrowing for the treatment of refractory angina: a multicentre prospective open-label clinical study (the REDUCER-I study)” in the September 2021 issue of the journal EuroIntervention.

Due to limitations necessitated by COVID-19, clinical trials have undergone a transformation. In tandem with telemedicine, decentralized clinical trials (DCTs) are gaining traction and, today, they are at the forefront of nearly every research-related conversation.

Todos Medical, Ltd., a comprehensive medical diagnostics and related solutions company, announced that it will be presenting at multiple industry conferences in October.